About Envera
Envera is a Healthcare company based in United States founded in 1999, and was acquired by Lesaffre in November 2017. Industrial microbiology services are provided across multiple sectors. Envera offers products and services including Fermentation Services and Product Analysis & Development. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its competitors include Avidity Biosciences, Vividion Therapeutics and Korro Bio; 3 of its 3 listed competitors have raised funding.
Company details
Envera was founded in 1999 and is based in the United States. Microbial technology services are offered to industries including animal care, aquaculture, bioremediation, consumer products, agriculture, and industrial biotechnology. Operations encompass the full value chain, from strain isolation and process development to scale-up, production, and formulation. Expertise in these areas supports client needs in applied microbiology.
- Headquarters United States
- Stage Acquired
- SectorsHealthcare
- Website envera.com
- Social LinkedIn
- Acquired by Lesaffre (Nov 2017)
Products & Services of Envera
Envera offers a comprehensive portfolio of products and services, including Fermentation Services and Product Analysis & Development.
Custom fermentation for producing viable microorganisms in various environments.
Analysis and development of microbial products for commercial applications.
Funding Insights of Envera
- Total Rounds 2
- First Round $517,604
(Feb 2008)
- Investors Count 1
All 2 funding rounds of Envera with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Envera
Envera has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Lesaffre and OSTI.GOV.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Scientific and technical information is managed and disseminated by OSTI.GOV. | osti.gov | Oak Ridge, United States | ||
Provider of yeast and its related products | 1853 | lesaffre.com |
Investor details for Envera
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Envera
4 dated milestones of Envera across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Envera is founded.
- Funding First funding round of $518K.
- Funding Latest funding round, Grant,.
- Exit Acquired by Lesaffre.
Competitors of Envera
Envera has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Vividion Therapeutics and Korro Bio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. |
Detailed competitors of Envera
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Envera
The website of Envera (envera.com) receives about 4.3K visits a month.
- Monthly visits4.3K
▲ 18.7% vs previous month
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Envera (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Envera
Complete news archive for Envera
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Envera
Envera was founded in 1999 and raised its 1st funding round 9 years after it was founded.
Envera is headquartered in United States.
Envera was founded in 1999 and is based in the United States. Microbial technology services are offered to industries including animal care, aquaculture, bioremediation, consumer products, agriculture, and industrial biotechnology. Operations encompass the full value chain, from strain isolation and process development to scale-up, production, and formulation. Expertise in these areas supports client needs in applied microbiology.
Envera's top competitors include Avidity Biosciences, Vividion Therapeutics and Korro Bio.
Envera offers Fermentation Services and Product Analysis & Development.
Yes. Envera was acquired by Lesaffre in November 2017.